Fengfeng Cai
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- CRISPR and Genetic Engineering 4
- Oncology 18
- Cancer Cells and Metastasis 9
- Co-authors
- Ewelina Biskup (16 shared papers)Xiao Yan Zhong (4 shared papers)Minghong Wang (7 shared papers)Bei Zhang (2 shared papers)Zeinab Barekati (1 shared paper)Weijie Chen (1 shared paper)Xiaoyan Lin (3 shared papers)Hongyi Zhang (4 shared papers)
- Journals
- Tumor Biology (5 papers)Frontiers in Oncology (5 papers)PLoS ONE (2 papers)Oncotarget (2 papers)Swiss Medical Weekly (2 papers)
- Partner nations
- ChinaSwitzerlandUnited States
In The Last Decade
Fengfeng Cai
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Cancer Research 359
- Oncology 289
- Molecular Biology 602
- Biotechnology 50
- Toxicology 19
Countries citing papers authored by Fengfeng Cai
This map shows the geographic impact of Fengfeng Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Cai more than expected).
Fields of papers citing papers by Fengfeng Cai
This network shows the impact of papers produced by Fengfeng Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Cai. The network helps show where Fengfeng Cai may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengfeng Cai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 140 | |
| 2 | 2019 | 119 | |
| 3 | 2021 | 67 | |
| 4 | 2021 | 60 | |
| 5 | 2022 | 55 | |
| 6 | 2016 | 48 | |
| 7 | 2013 | 46 | |
| 8 | 2021 | 42 | |
| 9 | 2019 | 42 | |
| 10 | 2022 | 40 | |
| 11 | 2011 | 36 | |
| 12 | 2021 | 35 | |
| 13 | 2021 | 33 | |
| 14 | 2017 | 27 | |
| 15 | 2012 | 25 | |
| 16 | 2013 | 21 | |
| 17 | 2014 | 18 | |
| 18 | 2017 | 18 | |
| 19 | 2014 | 18 | |
| 20 | 2025 | 16 |
About Fengfeng Cai
Fengfeng Cai is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer Genomics and Diagnostics (5 papers), Nanoplatforms for cancer theranostics (4 papers), CRISPR and Genetic Engineering (4 papers), Immunotherapy and Immune Responses (4 papers), Cancer Research and Treatments (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Cancer Research (359 citations), Oncology (289 citations), Molecular Biology (602 citations), Biotechnology (50 citations) and Toxicology (19 citations). Fengfeng Cai has collaborated with scholars based in China, Switzerland and United States. Frequent co-authors include Ewelina Biskup, Xiao Yan Zhong, Minghong Wang, Bei Zhang, Zeinab Barekati, Weijie Chen, Xiaoyan Lin, Hongyi Zhang, Marcus Vetter and Weijie Chen. Their work appears in journals such as Tumor Biology, Frontiers in Oncology, PLoS ONE, Oncotarget and Swiss Medical Weekly.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.